- 5640 malaria professionals are enjoying the free benefits of MalariaWorld today

Who's online
There are currently 4 users and 46 guests online.
Online users
- ric.ataide
- Bart Knols
- Inga
- Bart Knols
News Flash
Latest Jobs
Events 2010
Recent blog posts
- E-interview with Dr. Raphael N'Guessan (Ivory Coast, 1964)
- THIRD LAW FOR MALARIA
- Ngorongoro Run 2010 – The Race against Malaria
- Submit your own event!
- The Second International Conference, Malaria Vaccines for the World
- E-interview with Dr. Gunilla Priebe: Should more malaria research be based in Africa?
- Female Anopheles Trap
- Flightless Females : Can this be the ultimate answer to vector control?
- Can *Any* Malaria Control Program Pass “The 5/5/5 Test?”
- E-interview with Fredros Okumu (Kenya, 1981)
Active forum topics
- Introduce yourself to MalariaWorld members
- Malaria and Architecture (part 2): How would you make this house mosquito proof?
- Malaria and Architecture: Can house improvement play a role in reducing malaria?
- How should we increase free access to scientific publications?
- Malaria control through community participation is feasible. Malaria elimination not.
New forum topics
- Introduce yourself to MalariaWorld members
- How should we increase free access to scientific publications?
- Malaria and Architecture (part 2): How would you make this house mosquito proof?
- HIV/Malaria interaction; how do the two affect the lymphocyte subsets
- Emerging Vector-borne Diseases in a Changing European Environment
A new phenylpropanoid conjugated iridoid together with four known congeners was isolated from Morinda morindoides, used for the therapy of malaria traditionally in some African countries, as anti-malarial principles through bioassay-guided separation.
It is expected that this review will provide first-hand information on artemisinin chemistry to organic/medicinal chemists, and pharmacologists working on anticancer and anti-malarial drug development.